drugset / Trial / NCT04943783

Atorvastatin in the TREATment of Intracranial Unruptured VertebroBasilar Dissecting Aneurysms

NCT04943783

Unknown 40 enrolled Beijing Neurosurgical Institute
RandomizedParallel-groupQuadruple-blindScreening

Summary

This study was designed to whether there is a measurable reduction in inflammation in walls of unruptured vertebrobasilar dissecting aneurysms with atorvastatin.

Timeline

Start
2021-07-01
Primary completion
2022-01-01
Completion
2022-07-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Atorvastatin Small molecule 20 mg Oral